LifeVantage Declares Quarterly Dividend

Rhea-AI Summary

LifeVantage (Nasdaq:LFVN) announced that its Board of Directors approved a quarterly cash dividend of $0.045 per share. The dividend will be paid on December 15, 2025 to shareholders of record at the close of business on December 1, 2025. This is a declared cash distribution to common stockholders approved by the company’s board.

Positive

• Quarterly dividend of $0.045 per share
• Board approval by Board of Directors
• Payment date scheduled for December 15, 2025
• Record date set for December 1, 2025

Negative

• None.

SALT LAKE CITY, Nov. 04, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company’s Board of Directors has approved a quarterly cash dividend of $0.045 per share of common stock, which will be paid December 15, 2025 to all stockholders of record at the close of business on December 1, 2025.

About LifeVantage Corporation

LifeVantage Corporation (Nasdaq: LFVN), the Activation company, is a pioneer in nutrigenomics—the study of how nutrition and naturally occurring compounds can unlock your genes and the health coded within. Our products work with your unique biology and help your body make what it needs for health. The line of scientifically validated activators includes the flagship Protandim® family of products, TrueScience® Liquid Collagen, the newest MindBody GLP-1 System™, the comprehensive gut activator, P84, Activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System®, as well as AXIO® nootropic energy drink mixes, the full TrueScience® line of skin and hair care products, and Petandim®, a pet supplement formulated to combat oxidative stress in dogs. Our independent Consultants sell our products to Customers and share the business opportunity with entrepreneurs seeking to begin their own business. LifeVantage was founded in 2003 and is headquartered in Lehi, Utah. For more information, visit www.lifevantage.com.

Cautionary Note Regarding Forward Looking Statements

This document contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words and expressions reflecting optimism, satisfaction or disappointment with current prospects, as well as words such as "believe," "will," "hopes," "intends," "estimates," "expects," "projects," "plans," "anticipates," "look forward to," "goal," “may be,” and variations thereof, identify forward-looking statements, but their absence does not mean that a statement is not forward-looking. The declaration and/or payment of a dividend during any quarter provides no assurance as to future dividends, and the timing and amount of future dividends, if any, could vary significantly in comparison both to past dividends and to current expectations. Examples of forward-looking statements include, but are not limited to, statements we make regarding expected financial performance, including revenue and margins, executing against and the benefits of our key initiatives, future growth, including geographic and product expansion, expected financial performance, and expected dividend payments in future quarters. Such forward-looking statements are not guarantees of performance and the Company's actual results could differ materially from those contained in such statements. These forward-looking statements are based on the Company's current expectations and beliefs concerning future events affecting the Company and involve known and unknown risks and uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and discussed herein. These risks and uncertainties include, among others, further deterioration to the global economic and operating environments, as well as those discussed in greater detail in the Company's Annual Report on Form 10-K and the Company's Quarterly Report on Form 10-Q under the caption "Risk Factors," and in other documents filed by the Company from time to time with the Securities and Exchange Commission (the “SEC”). The Company cautions investors not to place undue reliance on the forward-looking statements contained in this document. All forward-looking statements are based on information currently available to the Company on the date hereof, and the Company undertakes no obligation to revise or update these forward-looking statements to reflect events or circumstances after the date of this document, except as required by law.

Investor Relations Contact:

Reed Anderson, ICR
(646) 277-1260
reed.anderson@icrinc.com

FAQ

What dividend did LifeVantage (LFVN) declare on November 4, 2025?

LifeVantage declared a $0.045 per share quarterly cash dividend on November 4, 2025.

When will LFVN shareholders receive the declared dividend?

The dividend will be paid on December 15, 2025 to shareholders of record as of December 1, 2025.

What is the record date for LifeVantage (LFVN) dividend for December 2025?

The record date is the close of business on December 1, 2025.

Who approved the December 2025 LFVN dividend and where was it announced?

The Board of Directors approved the dividend and the company announced it on November 4, 2025.

Is the declared LFVN dividend a cash or stock dividend for December 2025?

The company declared a quarterly cash dividend of $0.045 per share.

How can LFVN investors verify eligibility for the December 15, 2025 dividend?

Investors must be stockholders of record at the close of business on December 1, 2025 to be eligible for the December 15 payment.